0001209191-18-055471.txt : 20181017 0001209191-18-055471.hdr.sgml : 20181017 20181017201557 ACCESSION NUMBER: 0001209191-18-055471 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181017 FILED AS OF DATE: 20181017 DATE AS OF CHANGE: 20181017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klein Peter Justin CENTRAL INDEX KEY: 0001608710 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 181127439 MAIL ADDRESS: STREET 1: 5425 WISCONSIN AVE CITY: CHEVY CHASE STATE: MD ZIP: 20815 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-10-17 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0001608710 Klein Peter Justin 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 1 0 0 0 Series B Redeemable Convertible Preferred Stock Common Stock 2203 D Warrants to Purchase Series B Preferred Stock 0.12 Series B Redeemable Convertible Preferred Stock 103 D Each share of Preferred Stock is convertible at any time at the option of the holder into Common Stock on a one-for-one basis, has no expiration date and will convert into shares of Common Stock upon the closing of the Issuer's initial public offering. The warrants are immediately exercisable and terminate upon the closing of the Issuer's initial public offering. /s/ Sasha Keough, attorney-in-fact 2018-10-17